racemetirosine has been researched along with Neoplasms, Otorhinolaryngologic in 1 studies
alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Plotkin, M | 1 |
| Wurm, R | 1 |
| Eisenacher, J | 1 |
| Szerewicz, K | 1 |
| Michel, R | 1 |
| Schlenger, L | 1 |
| Pech, M | 1 |
| Denecke, T | 1 |
| Kuczer, D | 1 |
| Bischoff, A | 1 |
| Felix, R | 1 |
| Amthauer, H | 1 |
1 other study available for racemetirosine and Neoplasms, Otorhinolaryngologic
| Article | Year |
|---|---|
Combined SPECT/CT imaging using 123I-IMT in the detection of recurrent or persistent head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; alpha-Methyltyrosine; Diagnosis, Differential; Female; Follow-Up Stu | 2006 |